This is screening study to identify patients with Complement Factor I deficiencies. The primary objective is to identify participants with CFI deficiencies and assess the prevalence in the screened population.
Study Type
OBSERVATIONAL
Enrollment
113
Nephrology Consultants, LLC
Huntsville, Alabama, United States
Complement Factor I Deficiency Identification
Identification of participants with a CFI deficiency and percentage of those with a CFI deficiency versus total number of screened participants
Time frame: At Screening
Demographics, Disease Characteristics, Medication Use
Demographics, disease characteristics (including disease history), and disease-related medication use. Complement levels and mutation data will also be collected from medical records, if previously assessed and available.
Time frame: At Screening
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.